- Recommendation ID
- NG202/9
- Question
Oxygen therapy for OSAHS: What is the clinical and cost effectiveness of nocturnal oxygen compared with placebo in people with OSAHS who are unable to tolerate CPAP?
- Any explanatory notes
(if applicable) For a short explanation of why the committee made this recommendation and how it might affect practice, see the rationale section on oxygen therapy for OSAHS.
Full details of the evidence and the committee's discussion are in evidence review I: oxygen therapy.
Source guidance details
- Comes from guidance
- Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s
- Number
- NG202
- Date issued
- August 2021
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 31/08/2021 |